Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

Ontology Browser
Term:
Parent Terms Term With Siblings Child Terms
ceramide +     
(2R,3E)-N-((2S,3R,4E,8E,10E)-1,3-dihydroxyoctadeca-4,8,10-trien-2-yl)-2-hydroxy-6-methyloctadec-3-enimidic acid 
(2S,2′R,3R,4E,8E)-N-2′-hydroxyhexadecanoyl-2-amino-9-methyl-4,8-octadecadiene-1,3-diol 
(2S,2′R,3R,4E,8E)-N-2′-hydroxypentadecanoyl-2-amino-9-methyl-4,8-octadecadiene-1,3-diol 
(2S,2′R,3R,4E,8E)-N-2′-hydroxytetradecanoyl-2-amino-9-methyl-4,8-octadecadiene-1,3-diol 
(2S,3R,4E,8E)-N-hexadecanoyl-2-amino-9-methyl-4,8-octadecadiene-1,3-diol 
(2S,3R,4E,8E,9′Z,12′Z)-N-9′,12′-octadecadienoyl-2-amino-9-methyl-4,8-octadecadiene-1,3-diol 
(E,2R)-N-[(2S,3R,4E,8E)-1,3-dihydroxy-9-methyloctadeca-4,8-dien-2-yl]-2-hydroxyoctadec-3-enamide 
1-O-acyl-N-acylsphingosine +  
1-O-acylceramide +  
Asperamide A 
Cer(d16:1(4E)/20:0(2OH)) 
Cer(d16:1/18:0) 
Cer(d16:2(4E,6E)/22:1(13Z)(2OH)) 
Cer(d16:2(4E,6E)/24:0(2OH)) 
Cer(d18:0/17:0) 
Cer(d18:0/18:1(11Z)) 
Cer(d18:0/23:0) 
Cer(d18:0/h24:0) 
Cer(d18:1(8Z)/19:0) 
Cer(d18:1/18:1(11Z)) 
Cer(d18:2/18:1) 
ceramide 1-phosphate +   
ceramide 1-phosphonate +  
cerebroside +   
ganglioside +   
glycosylceramide +   
N-(1,3-dihydroxyoctadec-4-en-2-yl)acetamide 
N-(2-hydroxy-tetracosanoyl)-hexadecasphing-4-enine 
N-(2-hydroxyacyl)sphingoid 
N-(2-hydroxyhenicosanoyl)-4,8-sphingadienine 
N-(2-hydroxytridecanoyl)-phytosphingosine 
N-[(2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]acetamide 
N-[(2S,3R)-1,3-Dihydroxyoctadecan-2-yl]pentacosanimidic acid 
N-[(2S,3S,4R,8E)-1,3,4-Trihydroxy-8-octadecen-2-yl]icosanamide 
N-[(4E,8E)-1,3-dihydroxyoctadec4,8-dien-2-yl]hexadecanamide 
N-[(4E,8E)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]hexadecanamide 
N-[12-[(7-Nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-ceramide 
N-[omega-(acylyloxy)]acylsphin-4-enine +  
N-acyl-(4E,14Z)-sphingadienine +  
N-acyl-(4E,8E)-9-methylsphinga-4,8-dienine 
N-acyl-(4E,8E)-sphinga-4,8-dienine 
N-acyl-(4E,8E,10E)-sphinga-4,8,10-trienine 
N-acyl-(4E,8Z)-sphinga-4,8-dienine 
N-acyl-1-deoxy-4-hydroxysphinganine +  
N-acyl-1-deoxysphinganine 
N-acyl-1-deoxysphingosine 
N-acyl-15-methylhexadecasphing-4-enine +  
N-acylheptadecasphingosine +  
N-acylhexadecasphingosine 
N-acylsphingoid +   
N-acyltetradecasphing-4-enine 
N-docosanoyl-(4E,14Z)-sphinga-4,14-dienine 
N-docosanoyl-14-methylhexadecasphingosine 
N-henicosanoyl-14-methylhexadecasphingosine 
N-heptadecanoyl-14-methylhexadecasphingosine 
N-hexacosanoyl-14-methylhexadecasphinganine 
N-hexacosanoyl-14-methylhexadecasphingosine 
N-hexadecanoyl-14-methylhexadecasphingosine 
N-Octanoyl-D-sphingosine 
N-omega-linoleoyloxy-fatty acyl-sphingoid base 
N-palmitoyl-d-sphingosine 
N-pentacosanoyl-14-methylhexadecasphingosine 
N-tetracosanoyl-14-methylhexadecasphingosine 
N-tetracosenoyl-C17-sphingosine 
N-tricosanoyl-(4E,14Z)-sphinga-4,14-dienine 
N-tricosanoyl-14-methylhexadecasphingosine 
N-tricosenoyl-14-methylhexadecasphingosine 
oligoglycosylceramide +   
omega-hydroxy-ultra-long chain fatty acylceramide +  
omega-linoleoyloxy-O-ultra-long chain acylceramide +  
oxidized ceramide +  
Pecipamide 
phosphocerebroside +  
phytoceramides +   
A phytoceramide is a ceramide where the sphingoid base is hydroxylated at position 4. These backbone bases can be 14 to 20 carbons long, either straight chain or branched. The N-linked fatty acids are typically saturated or monounsaturated with chain lengths from 14 to 26 carbon atoms; the presence of a hydroxyl group on carbon 2 is fairly common. In the illustrated generalised structure, R1 = OH, OX (where X = acyl, glycosyl, phosphate, phosphonate, etc.), or H.

Synonyms
Related Synonyms: Formula=C5H8NO3R3 ;   N-acylphytosphingoid base ;   SMILES=O[C@H]([*])[C@@H](O)[C@H](C[*])NC([*])=O ;   a phytosphingolipid

paths to the root